CompletedNot Applicable

Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)

France, Italy132 participantsStarted 2020-10-22

Plain-language summary

Children supported by Extra-Corporeal Membrane Oxygenation (ECMO) present a high risk of neurological complications and cerebral autoregulation (CA) impairment may be a risk factor. The first objective is to investigate the association between CA impairments and neurological outcome assessed by the onset of an ANE. The secondary objective is to study the underlying mechanisms influencing CA.

Who can participate

Age range1 Day – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria : * Patients under the age of 18 years treated by ECMO Exclusion Criteria : * Lack of parental consent

What they're measuring

Association between CA metrics and neurological outcome

Timeframe: 1 year

Trial details

NCT IDNCT04548739

SponsorNantes University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-16

View on ClinicalTrials.gov More Acute Respiratory Distress Syndrome (ARDS) trials